First-line treatment selection with organoids of an EGFRm + TP53m stage IA1 patient with early metastatic recurrence after radical surgery and follow-up

Ziqi Jia, Yanyu Wang, Lei Cao, Yadong Wang, Yang Song, Xiaoying Yang, Zhongxing Bing, Zhili Cao, Peng Liu, Shuyang Zhang, Zexin Chen, Min Huang, Yan Yu, Han Han-Zhang, Jinlei Song, Daniel C. Christoph, Antonio Passaro, Cesare Gridelli, Tomoyuki Hishida, Naixin LiangShanqing Li

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)3764-3773
Number of pages10
JournalJournal of Thoracic Disease
Volume12
Issue number7
DOIs
Publication statusPublished - 2020 Jul 1

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Jia, Z., Wang, Y., Cao, L., Wang, Y., Song, Y., Yang, X., Bing, Z., Cao, Z., Liu, P., Zhang, S., Chen, Z., Huang, M., Yu, Y., Han-Zhang, H., Song, J., Christoph, D. C., Passaro, A., Gridelli, C., Hishida, T., ... Li, S. (2020). First-line treatment selection with organoids of an EGFRm + TP53m stage IA1 patient with early metastatic recurrence after radical surgery and follow-up. Journal of Thoracic Disease, 12(7), 3764-3773. https://doi.org/10.21037/jtd-20-1882